[ad_1]
This undated image provided by Dermira Inc. shows the drug Qbrexz. The US Food and Drug Administration has approved Qbrexza, the first drug developed to reduce excessive sweating, a common condition that can cause anxiety. Maker Dermira Inc. said Friday, June 29, 2018, that its drug has been approved for excessive underarm sweating. (Dermira Inc. via AP)
U.S. The regulators approved Friday the first drug developed specifically to reduce excessive sweating, a common condition that can cause anxiety and affect their social lives.
The Food and Drug Administration has approved Qbrexza for excessive underarm sweating and will be available in October. The drug is inside a tissue wiped daily on the skin to prevent the sweat glands from firing.
Its manufacturer, Dermira Inc., refused to disclose the price, as drug manufacturers normally do
excessive sweating, but only 1 in 4 get treatment. Current treatment options include Botox injections, surgery to remove sweat glands, procedures using lasers and other devices, and drugs approved for other conditions that block the body's chemical messengers to reduce production. sweat all over the body. Dermira said in a study that 53% of patients said that Qbrexza reduced sweat production by about half, compared to 28% in a comparison group. using non-medicinal tissue
Copyright 2018 The Associated Press. All rights reserved. This document may not be published, distributed, rewritten or redistributed.
Source link
